Correlation Between Chevron Corp and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Chevron Corp and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chevron Corp and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chevron Corp and Spero Therapeutics, you can compare the effects of market volatilities on Chevron Corp and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chevron Corp with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chevron Corp and Spero Therapeutics.
Diversification Opportunities for Chevron Corp and Spero Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Chevron and Spero is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Chevron Corp and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Chevron Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chevron Corp are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Chevron Corp i.e., Chevron Corp and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Chevron Corp and Spero Therapeutics
Considering the 90-day investment horizon Chevron Corp is expected to generate 0.35 times more return on investment than Spero Therapeutics. However, Chevron Corp is 2.82 times less risky than Spero Therapeutics. It trades about 0.36 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 14,902 in Chevron Corp on August 27, 2024 and sell it today you would earn a total of 1,334 from holding Chevron Corp or generate 8.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chevron Corp vs. Spero Therapeutics
Performance |
| Timeline |
| Chevron Corp |
| Spero Therapeutics |
Chevron Corp and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chevron Corp and Spero Therapeutics
The main advantage of trading using opposite Chevron Corp and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chevron Corp position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.The idea behind Chevron Corp and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |